Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients.

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Simon G. P. Funnell; W. E. Dowling; César Muñoz-Fontela; Pierre Stéphane Gsell; Donald E. Ingber; G. A. Hamilton; Leen Delang; Joana Rocha-Pereira; Suzanne J.F. Kaptein; Kai Dallmeier; Johan Neyts; Kyle Rosenke; E. de Wit; H. Feldmann; Pauline Maisonnasse; R. Le Grand; Matthew B. Frieman; C. M. Coleman

Journal title: "Nature Communications, Nature Publishing Group, 2020, 11 (1), pp.4253. ⟨10.1038/s41467-020-17907-w⟩"

Journal number: 40

Journal publisher: Nature Publishing Group

Published year: 2020

DOI identifier: 10.1038/s41467-020-17907-w

ISSN: 2041-1723